← Back to All Stocks

PRGO - Perrigo Company plc

Health Care

Price History

About

Industry

Drug Manufacturers - Specialty & Generic

Employees

8,100

Headquarters

Ireland


Company Overview

Perrigo Company plc provides over-the-counter health and wellness solutions in the United States, Europe, and internationally. The company operates through Consumer Self-Care Americas and Consumer Self-Care International segments. It offers upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and oral electrolyte beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers. The company also offers healthy lifestyle products, such as smoking cessation and well-being products; skin care products consisting of dermatological care, scar management, lice treatment, and other products for various skin conditions; women's health products comprising feminine hygiene and contraceptives; vitamins, minerals, and supplements; and other miscellaneous self-care products. It sells its products under the Compeed, Dr. Fresh, Firefly, Good Sense, Good Start, Mederma, Nasonex, Plackers, Prevacid24HR, REACH, Rembrandt, Steripod, Opill, Solpadeine, Coldrex, Physiomer, NiQuitin, ACO, ellaOne, and Compeed brands. The company also offers contract manufacturing services. It sells its products through retail drug, supermarket, and mass merchandise chains; e-commerce stores; wholesalers; pharmacies; drug and grocery retailers; and para-pharmacies. The company was formerly known as Perrigo Company and changed its name to Perrigo Company plc in December 2013. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.

Price

$10.74

52-Week Range

$9 $28

Dividend Yield

11.93%

Dividend Score

C

Dividend

Yield 11.93%
Annual $1.16
Payout 10950%
5Y Avg 3.63%

Valuation

P/E (TTM) N/A
Fwd P/E 4.5
P/B 0.50
PEG N/A

Profitability

Profit Margin -33.5%
Op Margin 10.2%
ROE -38.7%
ROA 2.4%

Financial Health

Current Ratio 2.76
Quick Ratio 1.17
Debt/Equity 131%

Cash Flow

Free CF $28M
Op CF $238M
Total Cash $532M

Analyst Consensus

Buy

4 analysts

Target: $17 $15 - $20
+58.3% implied

Dividend Growth

Most Recent Annual Growth

-21.20%

3-Year Avg Growth

-5.03%

5-Year Avg Growth

-0.02%

Annual Dividends

Year-over-Year Growth

Recent Dividend History

Ex-Dividend Date Amount
Mar 02, 2026 $0.2900
Aug 29, 2025 $0.2900
May 30, 2025 $0.2900
Mar 07, 2025 $0.2900
Nov 29, 2024 $0.2760
Aug 30, 2024 $0.2760
May 31, 2024 $0.2760
Mar 07, 2024 $0.2760
Nov 30, 2023 $0.2730
Aug 31, 2023 $0.2730
Jun 01, 2023 $0.2730
Mar 09, 2023 $0.2730
Dec 01, 2022 $0.2600
Sep 01, 2022 $0.2600
Jun 02, 2022 $0.2600
Feb 25, 2022 $0.2600
Dec 02, 2021 $0.2400
Sep 02, 2021 $0.2400
Jun 03, 2021 $0.2400
Mar 11, 2021 $0.2400

Unlock Full Access

Get unlimited access to all features including our powerful dividend screener, detailed stock analysis, and our dividend growth forecasting tool.

Full Screener

300+ proven dividend growth stocks

Growth Forecasts

Project returns with reinvestment

Deep Analysis

Fundamentals & metrics that matter